Avingtrans CEO Steve McQuillan appointed as non-executive Chairman of investee Adaptix

Avingtrans plc (LON:AVG) CEO, Steve McQuillan, has been appointed as the non-executive Chairman of emerging MedTech business, Adaptix, based in Oxford, UK. In parallel, Avingtrans is investing a further £2m in Adaptix, by means of a Convertible Loan Note. In 2021, Avingtrans invested £4m in Adaptix, for an 11.9% stake in the business, so this new investment represents a significant further endorsement of the Adaptix team and the plans for their disruptive 3D X-ray technology. It is intended that the additional funding will be used to take Adaptix up to the point of award of 510(k) approval from the FDA, for its Orthopaedic 3D X-ray product, with marketing and subsequent product sales in the USA expected to commence thereafter. Adaptix has already placed trial units of its Veterinary product in the USA and will commence sales in 2023.

It is intended that Steve will remain as Chairman until Adaptix appoints a replacement experienced MedTech Chair, likely to occur sometime in 2023. The key objective for Steve and for the replacement Chair, will be to lead Adaptix to a successful exit, currently planned for 2024.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Avingtrans

    More articles like this

    Avingtrans

    Avingtrans looking to strengthen the portfolio further (LON:AVG)

    Avingtrans’ Steve McQuillan discusses interim results, the performance of the main divisions, their medical division, stronger than average order book and what investors can expect in the coming year from the company in this exclusive interview with DirectorsTalk.

    Avingtrans

    Avingtrans appoints Willem Baralt as its new Chairman

    Avingtrans PLC (LON:AVG) has announced that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies, will succeed

    Avingtrans

    Avingtrans investee Adaptix receives 10(k) clearance from FDA

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that medical imaging technology associate company Adaptix Limited (Adaptix) has received 510(k) clearance from the U.S.

    Avingtrans

    Avingtrans ownership in Magnetica will increase to 74%

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that shareholders of Magnetica have approved an increase to Avingtrans’ ownership as part of a capital

    Avingtrans

    Avingtrans acquires the business and assets of Hevac

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that trading in the first 6 months of the financial year to 30 November 2022 was

    Avingtrans

    Avingtrans deliver solid results and a confident outlook (VIDEO)

    Avingtrans PLC (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss its results for the year ended 31st May 2022. Steve talks us through the highlights, the performance and highlights in the Energy division, involvement in the Medical division,

    Avingtrans

    Avingtrans revenue from continuing operations increased by 1.9% to £100.4m

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced its preliminary results for the year ended 31 May 2022. Financial Highlights ·      Revenue from

    Avingtrans

    Avingtrans’ Hayward Tyler awarded $7m nuclear contracts

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced Hayward Tyler, Inc has secured two new nuclear contracts worth a total of US

    Avingtrans

    Avingtrans results, visibility and M&A opportunities (Interview)

    Avingtrans PLC (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss its interim results for the six months ended 30 November 2021. Steve talks us through the highlights, its strong order book, updates us on the developments with Hayward

    Avingtrans

    Avingtrans’ PIE strategy continues to deliver robust results

    Avingtrans PLC (LON:AVG), the international engineering group which designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial sectors, has announced its interim results for the six months ended 30 November

    Avingtrans

    Avingtrans appoints Jo Reedman as an independent Non-Executive Director

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced the appointment of Jo Reedman, as an independent Non-Executive Director, effective on 1st March 2022.

    Avingtrans

    Booth welcomes HS2 CEO for site visit

    Booth Industries was delighted to welcome HS2 CEO Mark Thurston yesterday, to view its new purpose-built facility for the manufacture of safety doors for HS2 tunnels and meet staff working on the project. The £36.5million 10-year contract was

    No more posts to show